Additionally, in cases of poorly differentiated lung adenocarcinoma exhibiting rhabdoid morphology and tumor giant cells, immunohistochemical testing for SMARCA2 and SMARCA4 can effectively identify such tumors, which is highly significant for clinicians in selecting more precise therapeutic strategies.
← all excerpts
SMARCA2 Deficiency While Preserving SMARCA4 in Lung Adenocarcinoma Combined with Abnormal β-Catenin Expression.
1
—
—